{"name":"Alvogen Korea","slug":"alvogen-korea","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Meniace","genericName":"Meniace","slug":"meniace","indication":"Other","status":"marketed"},{"name":"Cholecaliferol","genericName":"Cholecaliferol","slug":"cholecaliferol","indication":"Other","status":"phase_1"},{"name":"bonviva","genericName":"bonviva","slug":"bonviva","indication":"Hypercalcemia","status":"phase_1"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Isobide","genericName":"Isobide","slug":"isobide","indication":"Ocular hypertension","status":"marketed"}]}],"pipeline":[{"name":"Meniace","genericName":"Meniace","slug":"meniace","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cholecaliferol","genericName":"Cholecaliferol","slug":"cholecaliferol","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Isobide","genericName":"Isobide","slug":"isobide","phase":"marketed","mechanism":"Small molecule","indications":["Ocular hypertension"],"catalyst":""},{"name":"bonviva","genericName":"bonviva","slug":"bonviva","phase":"phase_1","mechanism":"Geranylgeranyl pyrophosphate synthase, Farnesyl pyrophosphate synthase, Farnesyl pyrophosphate synthase","indications":["Hypercalcemia","Postmenopausal osteoporosis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE5RN0RKc2dGdWhtVl81OWFsQ0hJdmpsTGVnMnBXT2s4OC1mUkxpeU1sNDJaVEF3ZGV5Y0J6TjR3SExmUEV5aC14OFd1M1JHYndpejUzcGpUZy1zbHNUTldEMXh3aVlqZDhjUGE2TldhUXNubEd5?oc=5","date":"2025-05-26","type":"pipeline","source":"Businesskorea","summary":"Wegovy Dominates Domestic Obesity Market with 73% Share - Businesskorea","headline":"Wegovy Dominates Domestic Obesity Market with 73% Share","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1XbXB3bFRVc3Nqa3RHRnlYR1VTdFpIYW9aQ0VxUWJFWTB3eExHTVI5bENpb1k4UnowVUNrSmh6eUt1SXcwaHZRZHhIOGllLUtPeUtLajU4dUNISmNmMlZ2SnJ2ZFFqT1BFbXBaR3FB0gFyQVVfeXFMTmJ0bnZMdU05bGFJb2RBTWlfdnlhd25vQnlneURUWVNCbDV3bW5qa3d5Q1h2QXY3bXhGZGhIWXk2Y1lPQ044SGNGSnhveE9TSmtQZXk0aGtGOG0zdFpxVlRfRmdPbURfS3BLbUIwYldEeENB?oc=5","date":"2025-01-07","type":"pipeline","source":"koreabiomed.com","summary":"Contraceptive market faces reshuffle with new pills, sales rights transfers - koreabiomed.com","headline":"Contraceptive market faces reshuffle with new pills, sales rights transfers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9YSk50SjMyVGpBQ3JFZDFaSmlWZ2dxend4NXhtUGdkem9HeHNma0RVdTRGX3YtWW9aVExiYXdOTXZqS0VpTnNtUGVHR0h2bXJ2TDF3ZEZHakdlYm5SblZoSmhDSDRiaTZNaFg2ZFZR0gFyQVVfeXFMUEdHUlg3Q2xmVDhhckRFWW5Rcm9vY0w3MVJVTHZNOE9acjFaOVBUQ3pFdGVXM0Iwd2pLbUpPWVFCRjUzc0ZUN2Q2TnVuR0RhLTI4Z3JwaHNrVGJUNXl6YWdyZHQwbWxWb3I5VFlfMzBmWEhR?oc=5","date":"2024-05-16","type":"pipeline","source":"koreabiomed.com","summary":"Regulator orders Kukje Pharma to recall fluoxetine hydrochloride products - koreabiomed.com","headline":"Regulator orders Kukje Pharma to recall fluoxetine hydrochloride products","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNU09ackNndDBmNG0ydWZiY0tWT01NQlZoTHNQQjEwT3BNSUV0ajRxMUZxVllBYmpuOTFSMWhJYkh3V0tzcko5TXc2TkJyRkRYMUZKdldVbXBNelJPYXlVdnVoYmlrS0JKbTZodjkzSmoySkdMQUpfcGRoRGMtSkdldzB3dzZDWUs3VHVOcDR6MGczLXNmZjg0cA?oc=5","date":"2023-08-03","type":"pipeline","source":"BioWorld News","summary":"Amarin taps Lotus to expand Vazkepa in SE Asia, Korea - BioWorld News","headline":"Amarin taps Lotus to expand Vazkepa in SE Asia, Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNM0c1cV82ZnhwazBISG5DVDJVaGpKWEVwY3FpU2FGLWVFZkN4SWVCQ0lfZXphdXVJN1FDSUZtNmk4LWNOcWhWN09TeU4tNjBrMjRMSFFVVEt6ZzgxRDFuSnJpVFg4akFwUUhiMzh2WjlndjBiQWVMemVnZ2U3MHR6ZXljMVFkNHRvMUpzUmpsVEZfX0p0M1pPSUVHT28yeUxOSG1YTU1HMGxCcjF1bmRuQjVvNVJnVS02OGVHSF9qN0FYdw?oc=5","date":"2022-10-13","type":"patent","source":"Fierce Pharma","summary":"AstraZeneca hit with small fine in Korea over plot to stall generic of lucrative cancer med - Fierce Pharma","headline":"AstraZeneca hit with small fine in Korea over plot to stall generic of lucrative cancer med","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9wQWtYVDNMdzI1X1hwRW95MHIyVUItaDNhYnhRMDhXV1phRTQ1OGZfQUpaVnU2c09tQnZPanloeTY0ZkhEdkt6RnJUdGg2UHhoVVV1WVZiUVpWSFRtOEowd05UcU5GLXc0ZjFmQU9B0gFyQVVfeXFMTmNnVm9EaERxS3BEQ2huOGRJQzRMcnVSWUZ0YWZXWHpYX3NELTZoVnBNc1dQdmtoVHZTUU43TWNoc185cUQ5NWhaYWltR0xhUDh0S3d3Wnk3V0ZGdDMxV0JBd25aRjRTM1NsWUozS19qZlBn?oc=5","date":"2022-09-06","type":"pipeline","source":"koreabiomed.com","summary":"Qsymia's pursuit of Saxenda slows down in obesity market - koreabiomed.com","headline":"Qsymia's pursuit of Saxenda slows down in obesity market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNSVNzeFpTYzdOdjVIbS1jS1ZkNU40VWxmV1lQQVo4X25mb090RWgwUjlua0JGZTh3eWxrRXkyM05OM2ZwSzdLeU1wbl9SS2UxODFGdUZTRW9sUUNvYWxKV29ZRi1QVkkxVTR3U0x6NTBWa045Y01ldHJpQWlwbktfd0ZMSk9JanRVOHFOZHZwcHpraGFod3ZuQjJNcFFFRDFUZVkxVk14OW1hc3Zia3JnN3kzNEdVZUl4bU0zWmxR?oc=5","date":"2019-11-15","type":"patent","source":"Generics and Biosimilars Initiative","summary":"Alvogen gains exclusive rights to market parathyroid biosimilar in three countries - Generics and Biosimilars Initiative","headline":"Alvogen gains exclusive rights to market parathyroid biosimilar in three countries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE9aN3BfcC0yZGVrZEZpYVpOVUVnaTFuVTV5SHVQbXVtQnpNelFpU3VMcm1NZkF6TmNOUW5MSVVJQWVQN3VQZkF0SjUxNktNaTRuTVg4WUxFcnBfRzltTXc?oc=5","date":"2019-08-02","type":"patent","source":"뉴스와이어","summary":"Alvogen and Lotus Announce First to Launch Generic Version of Navelbine® Softgel Capsule in Europe - 뉴스와이어","headline":"Alvogen and Lotus Announce First to Launch Generic Version of Navelbine® Softgel Capsule in Europe - 뉴스와이어","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQMVJ4SW5lcXRSdHVoUU95NGwwU0YzQzVZZ2xXQ3RPaGx6d2drdW5fNnA5WTVDVXk5d3ZYMWxEamZhVkhvTHk2Q1dVY3BoeDhvOU5NOUwtYldqM1lTWjdET0w5UW1OTlFHZEVEclkteXpRZjVULXlyb1ZnQVZlYmFzcXJsWHpHTFMzQjFjR3N6bWwtaUF5V2xXcDFFUGxmcEh2dGItb0EzSW5OalpfbEo3bEQtMA?oc=5","date":"2017-09-26","type":"pipeline","source":"Bloomberg.com","summary":"CVC to Explore Options for $4 Billion Drugmaker Alvogen - Bloomberg.com","headline":"CVC to Explore Options for $4 Billion Drugmaker Alvogen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPamhYZU5FY3VjeWc1d2JidFo4MVU1RnVUY3dnRENOSEV3NDVqOTk5cVRSUTZKeHd0c0RkbU51NC1GNTh0MFhZeXZjM21WOVp4MGd6OXMxS3NPdmt4Q2txVGdRckdsS19PSEd2aEVLRDJ4VWxhSnpGdmdiOTNWQ29xQWV2MFNtUno2ZVRmX21QM1Y2NUtZbFdLRmQyM1ZfQUE?oc=5","date":"2017-09-26","type":"pipeline","source":"Fierce Pharma","summary":"CVC talks $4B Alvogen sale with Shanghai after just 2 years of ownership - Fierce Pharma","headline":"CVC talks $4B Alvogen sale with Shanghai after just 2 years of ownership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9IblNnN0tXWW9jaEZtNnJYZy1DR1BabWYxbFNTYUdQWmlBaWNsVlNvUEZFQUFvWVVSSk4zY0tlMVpjX3RoV2oxaVVZWFlRbHpYS1Nfdl93ay1oS2pfM0ViRTBoX2VDRGVFdU0ycdIBcEFVX3lxTE1TYXBuUmlXNGsxNUZkRFhYSHdVd2F5LVpfSTR3eUVjNTVTVTJKMU5Ma3VwNF9tM0xwa1h2T1pFOXF4WGdiTHF5TGM3Wk96WXdpcHVjd05LdGJVS2hpSDhKek5zaGJkdVQxdGRyWlJRdC0?oc=5","date":"2017-09-13","type":"pipeline","source":"koreabiomed.com","summary":"Alvogen Korea to sell Vivus’ obesity drug - koreabiomed.com","headline":"Alvogen Korea to sell Vivus’ obesity drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPLU5hMzJGZ3BERkN4Z0psUW56QjdNQ0pRQmJPczV3dE01czltVDlseDQ3Ui1MUkpFOHVqQUZRdWtiTDgtV3pFNjRxREtKU2FyVTlUSGZkdXV3amthZzduZl9SY1RHSmpvMmV6ODk3b3hkZDB1RWF4cUFKa2t0bXZpOHBack41bXQ3X2ZrSW5PYmo?oc=5","date":"2016-05-02","type":"pipeline","source":"Fierce Pharma","summary":"Alvogen opening $250M biologics plant in Iceland - Fierce Pharma","headline":"Alvogen opening $250M biologics plant in Iceland","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"marketed":2,"phase_1":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}